Category: Recommended

11th North West Lipid & Atherosclerosis Forum: 18 Sep 2018

Posted on by Guest Author

What: 11th North West Lipid & Atherosclerosis Forum

When: Tuesday, 18th September 2018

Where: Radisson BLU Hotel, Chicago Avenue, Manchester Airport, Manchester, M90 3RA

Programme

0830 – 0900 Registration & Coffee  
0900 Welcome Dr Handrean Soran
0905 First Session Chairs: Dr Michael France & TBC
0910–0940 Managing hypertension: clinical guidelines and how to individualise treatment? Professor Anthony Heagerty, University of Manchester, UK
0940-1010 A systematic evaluation of glucose lowering therapy and cardiovascular risk: past and present. TBC
1010-1040 Optimizing treatment of Hyperlipidaemia: quantitative evaluation of UK, USA and European guidelines Professor Paul Durrington, University of Manchester, UK
1040-1105 Case presentation

Moderated Panel discussion

 Dr Handrean Soran
1105 – 1135 Coffee  and Networking  
1135 Second session          Chairs: Professor Sean Carroll and Dr Basil Iissa
1135-1205 FCS: the disease burden, diagnosis and data from gene therapy. Prof Elisabeth Steinhagen-Thiessen, Berlin, Germany
1205-1335 Recent advances in lipid modification therapy: PCSK9i trials and new therapies for severe hypertriglyceridaemia Dr Handrean Soran, Manchester University Hospital, Manchester, UK
1235-1305 PCSK9, LDL-R and diabetes: from molecular mechanisms to clinical implications. Professor Giuseppe Danilo Norata, Milan, Italy
1305-1315 Panel discussion  
1315 – 1400 Lunch and Networking  
1400 Third session Chairs: Dr Rachelle Donn and Dr Lance Sandle
1400-1430 HDL cholesterol as a therapeutic target: A critical appraisal of previous clinical trials and how can we do better? TBC
 1430-1500 Autoimmunity against HDL/apoA-1: an emergent marker and mediator of cardiovascular risk. Prof Nicolas Vuilleumier, Geneva Faculty of Medicine, Switzerland
1500 – 1515 Coffee  and Networking  
1400 Fourth session Chairs: Dr Dermot Neely, Newcastle, UK & TBC
1510-1540 Lipid lowering nutraceuticals in clinical practice and recent advances Prof Maceij Banach, Warsaw, Poland
1540-1610 Lipoprotein (a) as a cardiovascular risk factor: what HEART UK says? Dr Jaimini  Cegla

Imperial College, London
1420–1440 Coffee and Networking

Feedback/Close

  
1550 END

7th International Academic and Research Conference

Posted on by Guest Author

5th August 2017 (Saturday)

University Place, University of Manchester, United Kingdom

 

Dear Colleague,

Re: Opportunity for an International Presentation, Prize and Publication!

Closing date for abstract submission: 2359 hours 7th May 2017 (Sunday)

On the 5th of August (Saturday) 2017, you may be interested in attending the above conference and presenting any work, research or clinical studies that you may have undertaken at your medical school/university. The work could be related to your intercalated or higher degree, special study module/component, short project, departmental study, clinical audit, case note review or a case report. The closing date for submission of abstracts is 7th May 2017 (Sunday).

This is a very good opportunity for you to:

  1. Present at an International Conference.
  2. Have the chance to win one of the number of prestigious prizes that will be on offer (prize at an International Conference).
  3. Prospect to interact with more than 200 doctors and students from different corners of the globe.
  4. Publish your abstract in a peer-reviewed international journal – World Journal of Medical Education and Research (www.wjmer.co.uk).
  5. Publish your full article in the above journal.

 

Please follow this link for more details and to register:

http://conference.doctorsacademy.org.uk/

 

Please submit your abstract by following this link:

http://www.abstracts.doctorsacademy.org.uk/

 

Thank you for your attention and we sincerely hope that you make use of this opportunity.

With very best wishes,

Organising committee

7th International Academic and Research Conference 2017

Doctors Academy

www.doctorsacademy.org

 

 

 

 

Impact of Obesity on Health

Posted on by Guest Author

RCP CPD approved for 5 credits. Code 100727

http://doctorsacademy.org/Course/Obesity/Home.htm

Date: 14th November 2015 (Saturday)

Time: 0900 – 1630

Venue : Mayo Building, Salford Royal Foundation Trust

Fee: Free to all healthcare professionals. Places are limited and will be offered on a ‘first-come-first-served’ basis.

Aimed at: General Practitioners, Physicians, Surgeons, Specialist Nurses and Dieticians with interest in obesity and bariatric surgery.

Description: Currently we are amidst an epidemic of obesity that is likely to worsen over the years as predicted by the ‘Foresight report for tackling obesity’. The crux of the problem is an imbalance between energy intake and energy expenditure.

The physical and psychological drivers inherent in human biology mean that the vast majority of us are predisposed to gaining weight.

Obesity not only leads to multiple comorbidities such as diabetes, sleep apnoea, metabolic syndrome, cardiovascular risk, stroke, arthritis and increased risk of cancer but also results in poor quality of life and impacts longevity.

Hence there is an urgent need for awareness and action at every level and not least the medical fraternity.

The purpose of this study day is to increase awareness and to review the current evidence and practice in the management of obesity. The day will also feature the establishment of a voluntary organisation “Greater Manchester Obesity Awareness and Support” with a view to share our knowledge and to develop strategies to tackle the obesity epidemic.

Early Steps into Research as a Qualified Doctor

Posted on by Louise Hunter

This event on Friday 6th November is being run by the Fellowship Academy (an initiative of the University of Manchester Faculty of Medical and Human Sciences), and is aimed at early career clinicians interested in pursuing a research career pathway. Please let all your trainees know!

More details can be found here, and you can download the programme here.

Anabolic steroid-induced hypogonadism

Posted on by Akheel Syed

Androgen- or anabolic steroid-induced hypogonadism (ASIH) is no longer confined to professional athletes; its prevalence among young men and teenagers using androgens and/or anabolic steroids (AAS) is rising fast, and those affected can experience significant symptoms.

Excellent review article on a topical area of endocrinology of increasing complexity published in Clinical Endocrinology.